Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke
- 1 December 2004
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 227 (1) , 49-53
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Prediction of Early Clinical Severity and Extent of Neuronal Damage in Anterior-Circulation Infarction Using the Initial Serum Neuron-Specific Enolase LevelArchives of Neurology, 2003
- Early Dramatic Recovery During Intravenous Tissue Plasminogen Activator InfusionStroke, 2002
- Utility of Perfusion-Weighted CT Imaging in Acute Middle Cerebral Artery Stroke Treated With Intra-Arterial Thrombolysis:Stroke, 2001
- Release of Glial Tissue–Specific Proteins After Acute StrokeStroke, 2000
- Early Neurobehavioral Outcome After Stroke Is Related to Release of Neurobiochemical Markers of Brain DamageStroke, 1999
- Diagnostic Impact and Prognostic Relevance of Early Contrast-Enhanced Transcranial Color-Coded Duplex Sonography in Acute StrokeStroke, 1998
- S-100 Protein and Neuron-Specific Enolase Concentrations in Blood as Indicators of Infarction Volume and Prognosis in Acute Ischemic StrokeStroke, 1997
- S-100 Protein: Serum Marker of Focal Brain Damage After Ischemic Territorial MCA InfarctionStroke, 1997
- Serum S-100 Protein, Relationship to Clinical Outcome in Acute StrokeAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1997
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995